CLINICAL_TRIALS
trial_result
· 2016-11-08
Clinical Trial Update: Dose-finding Study With Lu AA24530 in Major Depressive Disorder [Phase 2]
Summary
Phase 2 dose-finding trial of Lu AA24530 (vortioxetine) for major depressive disorder has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED